Assessing the clinical impact of CYP2C9 pharmacogenetic variation on phenytoin prescribing practice and patient response in an integrated health system : Pharmacogenetics and Genomics

Secondary Logo

Journal Logo

Original Articles

Assessing the clinical impact of CYP2C9 pharmacogenetic variation on phenytoin prescribing practice and patient response in an integrated health system

Fohner, Alison E.a,,b,,c; Ranatunga, Dilrini K.a; Thai, Khanh K.a; Lawson, Brian L.a; Risch, Neild; Oni-Orisan, Akinyemid,,e; Jelalian, Aline T.f; Rettie, Allan E.g; Liu, Vincent X.a; Schaefer, Catherine A.a

Author Information
Pharmacogenetics and Genomics 29(8):p 192-199, October 2019. | DOI: 10.1097/FPC.0000000000000383

Abstract

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid